Innoviva (INVA) Stock: Buy, Sell, or Hold?
$18.97
+0.11 (+0.58%)
▲
5d:
-1.4%
30d:
-9.54%
90d:
-10.48%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect INVA Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (80%)
Quality Score
50/100
Position
OVERSOLD
30-Day Fair Range
$20.15 – $21.39
Position: OVERSOLD
Forward P/E & Valuation
8.8x
CHEAP
vs 10.0x historical avg
Wall Street Target
$34.80
+83.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$18.66 / $21.65
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: INVA shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When INVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.99
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$26.07
27.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INVA is currently trading at $18.97, which is considered oversold relative to its 30-day fair value range of $20.15 to $21.39. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.8) compared to its historical average (10.0). Remarkably, the market is currently pricing in an annual earnings decline of 4.3% over the next few years. This pessimistic expectation contrasts with the company's recent 590.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, INVA is in a downtrend. The price is currently testing key support at $18.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $34.80 (+83.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INVA is in a downtrend. The price is currently testing key support at $18.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $34.80 (+83.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.15 -
$21.39
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Trading Range & Key Levels
30-Day Trading Range
$20.15 -
$21.39
Current vs Trading Range
OVERSOLD
Support Level
$18.66
Resistance Level
$21.65
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding INVA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 83.4% below Wall St target ($34.80)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
8.80
Wall Street Target
$34.80
(+83.4%)
Revenue Growth (YoY)
-1.6%
Earnings Growth (YoY)
590.4%
Profit Margin
44.1%
Valuation Discount vs History
-4.3% cheaper
PE vs Historical
8.8 vs 10.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.3%
(market-implied from PE analysis)
1-Year Target
$18.15
(-4%)
2-Year Target
$17.37
(-8%)
3-Year Target
$16.63
(-12%)
3-Yr Target (if PE normalizes)
(PE: 9→10)
$18.90
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 152.2%)
$144.51
(+662%)
Base:
(SPY PE: 8.8, Growth: 152.2%)
$64.02
(+238%)
Bear:
(PE: 7.5, Growth: 152.2%)
$54.42
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 8.13 | Current EPS (TTM): $2.32
Bull Case
$19.28
(+2%)
Analyst growth -7.1%, PE expands to 8.9
Base Case
$17.53
(-8%)
Market implied -7.1%, PE stable at 8.1
Bear Case
$12.82
(-32%)
Severe decline -20.0%, PE contracts to 6.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.8 to 10.0
Stabilization Target:
$21.56
(+13.7%)
PE Expansion Potential:
+13.7%
Share INVA Analysis
Share this live INVA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INVA)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jun 20, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish sentiment prevails on StockTwits regarding $INVA, with traders referencing the transformative potential of a previous company, $KYTX, as a comparison.
Key Retail Themes:
Bullish sentiment
Transformation potential
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:39 PM ET
Data refreshes hourly during market hours. Next update: 8:39 PM
Data refreshes hourly during market hours. Next update: 8:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 58 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Advanced INVA Option Strategies
Professional options setups generated by AI based on today's INVA price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INVA Research Pages
